Adam Woodrow, VP & Chief Commercial Officer at Paratek Pharmaceuticals, Inc. (PRTK), sold 2,659 shares at $8.96 ($24K) on 2018-10-15, disclosed to the SEC on 2018-10-16.
Scheduled sale ($24k) by VP & Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PRTK | SELL | 2022-11-01 | $16K | — | Filing → |
| PRTK | SELL | 2021-12-15 | $269K | — | Filing → |
| PRTK | SELL | 2021-08-18 | $56K | — | Filing → |